HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral

HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral

Hepatitis B core-related antigen (HBcrAg) is a predictor of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients. Studies on anti-viral therapy have shown that the use of NUC therapy in HBV patients could reduce the incidence of HCC. However, the incidence of HCC continues to increas...

Full description

Bibliographic Details
Main Authors:	Kuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Sherry Yueh-Hsia Chiu, Tsung-Hui Hu
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Viruses
Subjects:	chronic B hepatitis hepatitis B core-related antigen hepatocellular carcinoma liver cirrhosis anti-viral therapy
Online Access:	https://www.mdpi.com/1999-4915/14/12/2671

Similar Items

Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research
by: Ying-Nan Tsai, et al.
Published: (2024-04-01)

Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation
by: Yandi Xie, et al.
Published: (2023-06-01)

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection
by: Jia-Feng Wu, et al.
Published: (2024-05-01)

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients
by: Jing Zhao, et al.
Published: (2023-03-01)

End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients
by: Sylvia M. Brakenhoff, et al.
Published: (2023-02-01)

Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
by: Satinder P. Kaur, et al.
Published: (2022-02-01)

Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis
by: Liangliang Xu, et al.
Published: (2022-09-01)

Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B
by: Young-Suk Lim, et al.
Published: (2023-04-01)

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
by: I-Chin Wu, et al.
Published: (2021-05-01)

A Case of Composite Hepatocellular Carcinoma and Neuroendocrine Carcinoma in a Patient with Liver Cirrhosis Caused by Chronic Hepatitis B
by: Eun Young Yun, et al.
Published: (2016-08-01)

IMMUNOLOGICAL FEATURES IN LIVER CIRRHOSIS INDUCED BY HEPATITIS B VIRUS
by: O. I. Urazova, et al.
Published: (2014-07-01)

Well‐controlled viremia reduces the progression of hepatocellular carcinoma in chronic viral hepatitis patients treated with lenvatinib
by: Ya‐Wen Hsiao, et al.
Published: (2023-12-01)

Metabolomics and network analysis uncovered profound inflammation-associated alterations in hepatitis B virus-related cirrhosis patients with early hepatocellular carcinoma
by: Zhiyong Du, et al.
Published: (2023-05-01)

Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
by: Chih-Lin Lin, et al.
Published: (2023-07-01)

HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative
by: Tai-Chung Tseng, et al.
Published: (2024-01-01)

Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib
by: Yuan-Hung Kuo, et al.
Published: (2022-08-01)

Subtle Hepatocellular Carcinoma: A Persisting Role for Alpha-Fetoprotein Monitoring in High-Risk Patients with Cirrhosis
by: Barry Schlansky, et al.
Published: (2011-10-01)

Profiles of Clinical and Liver Function Test of Hepatitis B and C Patients with Liver Cirrhosis
by: Andreas Novaldi Watang, et al.
Published: (2023-01-01)

Outcomes of hepatitis B immunoglobulin and hepatitis B vaccination in high-risk newborns born to HBeAg-positive mothers
by: Chen-Hsuan Wu, et al.
Published: (2022-10-01)

Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019
by: Kwong-Ming Kee, et al.
Published: (2022-12-01)

Comparisons of Viral Etiology and Outcomes of Hepatocellular Carcinoma Undergoing Liver Resection between Taiwan and Vietnam
by: Song-Huy Nguyen-Dinh, et al.
Published: (2022-11-01)

Case report: Hepatic tuberculosis mimicking hepatocellular carcinoma in a patient with cirrhosis induced by hepatitis B virus
by: Na Hu, et al.
Published: (2022-11-01)

Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals
by: Ke Shi, et al.
Published: (2023-02-01)

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
by: Rani Burm, et al.
Published: (2023-03-01)

Evaluation of hepatitis A, B, and C serology in patients with cirrhosis and intensive alcohol consumption
by: Sezgin Vatansever, et al.
Published: (2018-06-01)

Antiviral therapy effectively improves liver hemodynamics as evidenced by serum biomarker and contrast-enhanced ultrasound examinations in patients with hepatitis B cirrhosis
by: Xiaoyong Xu, et al.
Published: (2018-09-01)

Presence of diabetes further heightens hepatocellular carcinoma risk in patients with hepatitis B or hepatitis C virus-related cirrhosis: A meta-analysis
by: Ye Zang, et al.
Published: (2023-08-01)

Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma
by: Qingquan Bai, et al.
Published: (2023-12-01)

ASSESSMENT OF THE ACTUAL AND POTENTIAL EPIDEMIOLOGYCAL SITUATION OF THE VIRAL HEPATITIS C AND B BASED BY LABORATORY DATA IN THE “DOCTOR PARAMONOV’S CLINIC” IN SARATOV CITY AND SARATOV REGION
by: V.V. NIKITINA, et al.
Published: (2017-04-01)

Expression and Correlation of MIF and ERK1/2 in Liver Cirrhosis and Hepatocellular Carcinoma Induced by Hepatitis B
by: Jia D, et al.
Published: (2023-04-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Giacomo Emanuele Maria Rizzo, et al.
Published: (2022-05-01)

Gut Microbiota and Chronic Hepatitis B and C Viruses-Induced Cirrhosis
by: Parisa torkamanzadeh asadabadi, et al.
Published: (2021-01-01)

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
by: Ruipeng Zheng, et al.
Published: (2020-06-01)

Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy
by: Yuh-Ying Liu, et al.
Published: (2022-08-01)

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
by: Jae Seung Lee, et al.
Published: (2022-12-01)

Upregulated Expression of a Unique Gene by Hepatitis B x Antigen Promotes Hepatocellular Growth and Tumorigenesis
by: Zhaorui Lian, et al.
Published: (2003-05-01)

Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in chronic hepatitis B patients
by: Chen-Chih Liao, et al.
Published: (2015-06-01)

Public knowledge and attitudes toward liver diseases and liver cancer in the Brazilian population: a cross sectional studyResearch in context
by: Paulo Lisboa Bittencourt, et al.
Published: (2023-07-01)

Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
by: Hou Y, et al.
Published: (2024-03-01)